Probiotic Dietary Supplement Market

Probiotic Dietary Supplement Market: Nurturing Gut Health with Probiotic Supplements, Thorough Market Segmentation Analysis, Identification of Health Benefits, Regulatory Landscape Evaluation, and Key Player Insights

A Detailed Analysis of the Probiotic Dietary Supplement Market, examining market trends, growth potential, and industry challenges

Category: Life Sciences Published Date : May-23 ID: CVC-52663 Format: PDF Pages: 295

Report Highlights According to a research survey conducted by ChemView Consulting, the Probiotic Dietary Supplement Market was worth US$ 23.42 Bn. The market is expected to grow at a CAGR of 14.10% between 2023 and 2033 to reach US$ 87.6 Bn by 2033 end.



Report Includes

Research Scope/Taxonomy:

  • Market Analysis by Product Form:
    • Capsules
    • Tablets
    • Powders
    • Liquid
    • Gummies
    • Others
  • Market Analysis by Strain Type:
    • Lactobacillus
    • Bifidobacterium
    • Streptococcus
    • Others
  • Market Analysis by Distribution Channel:
    • Pharmacies & Drug Stores
    • Supermarkets & Hypermarkets
    • Online Retail
    • Others
  • Market Analysis by Region:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa






Analyst Credentials

Research Scope/Taxonomy:

  • Danone S.A.
  • Nestlé S.A.
  • Lallemand Inc.
  • Chr. Hansen Holding A/S
  • Groupe Lactalis
  • Probi AB
  • Yakult Honsha Co., Ltd.
  • Biogaia AB
  • DuPont de Nemours, Inc.
  • Merck KGaA
  • BioGaia
  • Now Health Group, Inc.
  • Perfetti Van Melle
  • Morinaga Milk Industry Co., Ltd.
  • Pfizer Inc.
  • Amul
  • Mother Dairy Fruit & Vegetable Pvt. Ltd.
  • Abbott Laboratories
  • Bio-K Plus International Inc.
  • Swanson Health Products, Inc.
  • Renew Life Formulas, Inc.
  • Probiogen
  • Kibow Biotech, Inc.
  • Bio-Kult
  • Church & Dwight Co., Inc.

1.1. Global Market Snapshot

1.2. Key Success Factors

1.3. Strategic Analysis and Recommendations

2.1. Market Taxonomy

2.2. Market Definitions

3.1. Preliminary Investigation & Research Design

3.2. Secondary Research & Primary Research

3.3. Data Analysis & Econometric Modelling

3.4. Expert Data Validation

4.1. Supply-Side Trends

4.2. Demand-Side Trends

5.1. Global Market Value (US$ Mn) Analysis, 2017 – 2032

5.2. Incremental $ Opportunity Index, 2022-2032

5.3. Global Market Volume (Tons) Analysis, 2017 – 2032

6.1. Regional Level Pricing Analysis and Forecast

6.1.1. Manufacturers Level Pricing

6.1.2. Distributor Level Pricing

6.2. Global Pricing Analysis Benchmark

6.3. Cost Breakdown Analysis

7.1. Cross Analysis of Strain TypeW.R.T. Type

8.1. Regional Supply Vs. Demand Gap Assessment

8.2. Top Producing Countries Analysis

9.1. Macroeconomic Factors

9.2. Forecast Factors

9.3. Market Dynamics

9.3.1. Driver

9.3.2. Restraint

9.3.3. Opportunity

9.4. Supply Chain Analysis

9.4.1. List Raw Material Suppliers

9.4.2. List of Manufacturers

9.4.3. List of Distributors

9.4.4. List of End-Users

9.4.5. End-Users Consumption Analysis

9.4.6. Average Profitability Margin Analysis

9.5. Covid-19 Impact Assessment

9.5.1. Economy/Cluster Projections

9.5.2. Covid-19 Economic Assessment

9.5.3. Impact on Target Market

9.5.4. Recovery Scenario

9.6. Regulatory Framework

9.6.1. Regulations of Key Countries

9.6.2. Potential Impact of Regulations

9.7. Porter’s Five Forces Analysis

9.8. Technology Landscape

10.1. Introduction

10.2. Key Market Trends

10.3. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Product Form [Value (US$ Mn) and Volume (Tons) Analysis]

10.3.1. Capsules

10.3.2. Tablets

10.3.3. Powders

10.3.4. Liquid

10.3.5. Gummies

10.3.6. Others

10.4. Market Attractiveness Analysis by Product Form

11.1. Introduction

11.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Strain Type [Value (US$ Mn) and Volume (Tons) Analysis]

11.2.1. Lactobacillus

11.2.2. Bifidobacterium

11.2.3. Streptococcus

11.2.4. Others

11.3. Market Attractiveness Analysis by Strain Type

12.1. Introduction

12.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Distribution Channel [Value (US$ Mn) and Volume (Tons) Analysis]

12.2.1. Pharmacies & Drug Stores

12.2.2. Supermarkets & Hypermarkets

12.2.3. Online Retail

12.2.4. Others

12.3. Market Attractiveness Analysis by Distribution Channel

13.1. Introduction

13.2. Key Market Trends

13.3. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Region [Value (US$ Mn) and Volume (Tons) Analysis]

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. Asia-Pacific

13.3.5. Middle East

13.3.6. Africa

13.4. Market Attractiveness Analysis by Region

14.1. Introduction

14.2. Key Market Trends

14.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

14.3.1. By Country

14.3.1.1. U.S.

14.3.1.2. Canada

14.3.2. By Product Form

14.3.3. By Strain Type

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product Form

14.4.3. By Strain Type

14.4.4. By Distribution Channel

15.1. Introduction

15.2. Key Market Trends

15.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

15.3.1. By Country

15.3.1.1. Brazil

15.3.1.2. Mexico

15.3.1.3. Rest of Latin America

15.3.2. By Product Form

15.3.3. By Strain Type

15.3.4. By Distribution Channel

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product Form

15.4.3. By Strain Type

15.4.4. By Distribution Channel

16.1. Introduction

16.2. Key Market Trends

16.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

16.3.1. By Country

16.3.1.1. Germany

16.3.1.2. Italy

16.3.1.3. France

16.3.1.4. UK

16.3.1.5. Spain

16.3.1.6. Netherlands

16.3.1.7. Norway

16.3.1.8. Russia

16.3.1.9. Rest of Europe

16.3.2. By Product Form

16.3.3. By Strain Type

16.3.4. By Distribution Channel

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product Form

16.4.3. By Strain Type

16.4.4. By Distribution Channel

17.1. Introduction

17.2. Key Market Trends

17.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

17.3.1. By Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.1.4. India

17.3.1.5. Indonesia

17.3.1.6. Thailand

17.3.1.7. Vietnam

17.3.1.8. Australia & New Zealand

17.3.1.9. Rest of Asia-Pacific

17.3.2. By Product Form

17.3.3. By Strain Type

17.3.4. By Distribution Channel

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product Form

17.4.3. By Strain Type

17.4.4. By Distribution Channel

18.1. Introduction

18.2. Key Market Trends

18.3. Pricing Analysis

18.4. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

18.4.1. By Country

18.4.1.1. Saudi Arabia

18.4.1.2. Turkey

18.4.1.3. U.A.E.

18.4.1.4. Rest of the Middle East

18.4.2. By Product Form

18.4.3. By Strain Type

18.4.4. By Distribution Channel

18.5. Market Attractiveness Analysis

18.5.1. By Country

18.5.2. By Product Form

18.5.3. By Strain Type

18.5.4. By Distribution Channel

19.1. Introduction

19.2. Key Market Trends

19.3. Pricing Analysis

19.4. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]

19.4.1. By Country

19.4.1.1. South Africa

19.4.1.2. Nigeria

19.4.1.3. Egypt

19.4.1.4. Rest of Africa

19.4.2. By Product Form

19.4.3. By Strain Type

19.4.4. By Distribution Channel

19.5. Market Attractiveness Analysis

19.5.1. By Country

19.5.2. By Product Form

19.5.3. By Strain Type

19.5.4. By Distribution Channel

20.1. Tier Structure Breakdown

20.2. Market Share Analysis

20.3. Production Capacity Analysis

20.4. Company Footprint Analysis

20.4.1. Product Footprint of Players

20.4.2. Regional Footprint of Players

20.4.3. Channel Footprint of Players

20.5. Brand Preference Analysis

20.6. Competition Dashboard

21.1. Danone S.A.

21.1.1. Company Overview

21.1.2. Product & Financial Portfolio

21.1.3. Manufacturing Facilities

21.1.4. Recent Developments

21.1.5. SWOT Analysis

21.1.6. Strategy Overview

21.2. Nestlé S.A.

21.3. Lallemand Inc.

21.4. Chr. Hansen Holding A/S

21.5. Groupe Lactalis

21.6. Probi AB

21.7. Yakult Honsha Co., Ltd.

21.8. Biogaia AB

21.9. DuPont de Nemours, Inc.

21.10. Merck KGaA

21.11. BioGaia

21.12. Now Health Group, Inc.

21.13. Perfetti Van Melle

21.14. Morinaga Milk Industry Co., Ltd.

21.15. Pfizer Inc.

21.16. Amul

21.17. Mother Dairy Fruit & Vegetable Pvt. Ltd.

21.18. Abbott Laboratories

21.19. Bio-K Plus International Inc.

21.20. Swanson Health Products, Inc.

21.21. Renew Life Formulas, Inc.

21.22. Probiogen

21.23. Kibow Biotech, Inc.

21.24. Bio-Kult

21.25. Church & Dwight Co., Inc.